Ovarian Neoplasms: all 2,757 studies
Page 1 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- Folate Receptor Alpha (FRα) Expression and Heterogeneity in Epithelial Ovarian CancerRecruitingNCT07889843
- Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic LesionsRecruitingNCT07883798
- AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before SurgeryNot yet recruitingNCT07883551
- Effects of Web-Based Ovarian Cancer Awareness Education on Women's Health Beliefs and Risk-Reducing BehaviorsNot yet recruitingNCT07882485Not applicable
- EHR Intervention to Increase HBOC Genetic TestingRecruitingNCT07876349Not applicable
- Safety in Ovarian Cancer for Average-Risk Women - AnalysisNot yet recruitingNCT07872644Not applicable
- A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)Not yet recruitingNCT07870278Phase 1
- Dermatological Effects and Quality of Life in Oncology PatientsNot yet recruitingNCT07869186Not applicable
- Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic SurgeryRecruitingNCT07860203Not applicable
- Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care Maintenance Treatment After First-line (1L) Platinum-based Chemotherapy in Participants With Ovarian CancerNot yet recruitingNCT07859215Phase 3
- Contrast-enhanced Ultrasound Evaluation of Indeterminate Ovarian Lesions: Prospective Multicenter StudyNot yet recruitingNCT07849543Not applicable
- Trastuzumab Rezetecan Plus Bevacizumab in Platinum-Sensitive Recurrent Ovarian CancerNot yet recruitingNCT07843303Phase 2
- Imlunestrant/Abemaciclib/Selinexor in Ovarian and EndometrialNot yet recruitingNCT07832227Phase 2
- A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian CancerRecruitingNCT07822646Phase 3
- Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian CancerRecruitingNCT07816666Phase 3
- Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid TumorsNot yet recruitingNCT07815951Phase 1
- Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and AtorvastatinNot yet recruitingNCT07815704Phase 2
- A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial EnrollmentNot yet recruitingNCT07814872
- A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid TumorsRecruitingNCT07814248Phase 1
- A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM CancersNot yet recruitingNCT07811297Phase 1/2
- CanRisk-Based Ovarian Cancer Risk Assessment Versus Standard Practice (DISARM CSA)RecruitingNCT07809659Not applicable
- HERCULES: Ultrasound-Based Liver Involvement Classification in Ovarian CancerNot yet recruitingNCT07808320
- A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsRecruitingNCT07807956Phase 1
- Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone as First-Line Maintenance Therapy in Ovarian Cancer Overexpressing Cyclin E1Not yet recruitingNCT07797283Phase 3
- Machine Learning Algorithms Incorporating Radiomic Ultrasound FeaturesNot yet recruitingNCT07793201
- A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03)Not yet recruitingNCT07791732Phase 3
- 89Zr-DFO-Mirvetuximab PET/CT Imaging for Companion Diagnosis and Response Evaluation in Ovarian CancerNot yet recruitingNCT07790939Early Phase 1
- Real-World Study of Niraparib in First-Line Maintenance Therapy for Advanced Epithelial Ovarian CancerRecruitingNCT07783022
- Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)RecruitingNCT07782164
- Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerNot yet recruitingNCT07781852Early Phase 1
- Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian CancerNot yet recruitingNCT07779538Phase 3
- A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.RecruitingNCT07778498Phase 1/2
- A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)RecruitingNCT07776691Phase 3
- Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian CancerNot yet recruitingNCT07776171Phase 2
- Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtientsNot yet recruitingNCT07771400
- Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic VariantsNot yet recruitingNCT07764744Not applicable
- Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer PreventionNot yet recruitingNCT07761416Early Phase 1
- 68Ga-SorB PET/CT Imaging in Patients With Solid TumorsRecruitingNCT07760012Not applicable
- Implementation of New Models of Ovarian Carcinoma Resistant to TherapyNot yet recruitingNCT07757711
- Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.RecruitingNCT07755436Phase 1
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2
- Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)Not yet recruitingNCT07747506Phase 2
- A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)RecruitingNCT07743164Phase 3
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast CancerRecruitingNCT07741968Not applicable
- Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian CancerRecruitingNCT07736937Phase 1/2
- Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?RecruitingNCT07733505Phase 1
- Analysis of Breath Volatile Organic Compounds Using Mass SpectrometryNot yet recruitingNCT07732686
- A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After SurgeryRecruitingNCT07724106Phase 1
- Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and PembrolizumabNot yet recruitingNCT07720180Phase 2
- Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell CancerRecruitingNCT07718854Phase 2
- Predictors of Cognitive Decline and Delirium in Older Women With Ovarian CancerNot yet recruitingNCT07716800
- A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid TumorsRecruitingNCT07715747Phase 1
- A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian CancerRecruitingNCT07714668Phase 2
- Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological MalignanciesNot yet recruitingNCT07702721
- Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]Not yet recruitingNCT07694427Phase 3
- Innovative Ovarian Cancer Biomarker AssaysRecruitingNCT07693894
- A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）Not yet recruitingNCT07690332
- Study of NTB-928 in R/R OCRecruitingNCT07690189Phase 1
- A Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02)RecruitingNCT07684612Phase 3
- A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After SurgeryRecruitingNCT07676890Phase 1
- PROV-MESH: Prophylactic Ovarian Cancer MESHRecruitingNCT07676370Not applicable
- IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian CancerNot yet recruitingNCT07674615Phase 1
- Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer PatientsRecruitingNCT07673861Not applicable
- Iparomlimab and Tuvonralimab Plus Chemotherapy as Neoadjuvant Therapy for Ovarian Cancer（Phase II）Not yet recruitingNCT07673835Phase 2
- INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE StudyRecruitingNCT07671937Not applicable
- Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line TherapyNot yet recruitingNCT07670962
- Evaluation of XYA02 in Patients With Advanced Solid TumorsRecruitingNCT07670312Phase 1/2
- An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian CancerRecruitingNCT07667751Phase 2
- Reirradiation and Total Ablative Strategies for Recurrent Gynecologic CancerRecruitingNCT07667192
- Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerRecruitingNCT07665515Phase 1
- A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.Not yet recruitingNCT07664735Phase 1
- Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Chemotherapy as Neoadjuvant Therapy for Advanced Ovarian CancerNot yet recruitingNCT07663513Phase 2
- NK521 in the Treatment of Advanced Solid TumorsNot yet recruitingNCT07657416Early Phase 1
- A Study of DAT-2645 in Patients With BRCA1/2 Mutations or HRD-Positive Ovarian CancerNot yet recruitingNCT07652073Phase 2
- To Evaluate the Safety of Autologous Tumor-infiltrating Lymphocytes(TILs) for the Treatment of Recurrent Ovarian CancerRecruitingNCT07651124Not applicable
- Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian CancerNot yet recruitingNCT07647653Phase 2
- Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic OncologyNot yet recruitingNCT07645716
- 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid TumorsNot yet recruitingNCT07639801Not applicable
- Prehabilitation in High-risk Oncologic SurgeryRecruitingNCT07638410Not applicable
- Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian CancerNot yet recruitingNCT07637851Phase 1/2
- The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced CancerRecruitingNCT07636200Not applicable
- Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian CancerNot yet recruitingNCT07634094Phase 2
- An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard TherapyNot yet recruitingNCT07631871Phase 2
- Preventing Ovarian Cancer Through Opportunistic Salpingectomy at the Time of Laparoscopic CholecystectomyNot yet recruitingNCT07625137Not applicable
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT07623369Phase 1
- Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2RecruitingNCT07617753Phase 1/2
- Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian CancerRecruitingNCT07616310Not applicable
- Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast CancerRecruitingNCT07614620Not applicable
- A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid MalignanciesRecruitingNCT07613723Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid TumorRecruitingNCT07612891Phase 1/2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D MutationsRecruitingNCT07610798Phase 1/2
- Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Ovarian Cancer SurgeryNot yet recruitingNCT07609082Not applicable
- An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaRecruitingNCT07604766Phase 3
- Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer DetectionNot yet recruitingNCT07593833
- Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer SurgeryNot yet recruitingNCT07593339Not applicable
- Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid TumorsRecruitingNCT07593092Phase 1
- Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian CancerNot yet recruitingNCT07591831Phase 2
- Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian CancerRecruitingNCT07589543Phase 1/2
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2